Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -3.62% vs -5.52% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -1.52% vs -2.71% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 1.64% vs -9.02% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -100.00% vs -12.09% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of GlaxoSmithKline Pakistan Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -3.62% vs -5.52% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -3.69% vs 6.97% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -1.52% vs -2.71% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 5.72% vs 2,860.89% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 1.64% vs -9.02% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 33.35% vs 657.21% in Sep 2024
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






